The Food and Drugs Authority (FDA) has revoked the marketing authorisation of Omama Herbal Mixture following laboratory tests that indicated the product had been contaminated with various prescription-only medications.
In a statement issued on Friday, the FDA announced that its market surveillance, carried out in partnership with the Ghana Police Service, revealed that Omama Herbal Mixture included Diazepam, Metronidazole, Paracetamol, and Niacinamide — all of which are allopathic drugs.
The Authority stated that the herbal mixture was registered as a herbal medicinal product intended for the treatment of malaria and appetite loss, and thus should not include any synthetic or prescription drugs.
“The medicines found in Omama Herbal Mixture are dangerous when taken without prescription and/or advice from a qualified health professional,” the FDA warned.
The Authority has urged the public to cease using the product immediately, as its consumption presents significant health hazards.
In the meantime, the FDA has indicated that it is collaborating with Omama Herbal Group Limited to withdraw all affected products from the market for safe disposal, and that suitable regulatory measures, including criminal prosecution, will be pursued.
The statement reassured the public of the FDA’s ongoing dedication to safeguarding public health and safety.
“The FDA wishes to assure the public that it will not relent in its effort to ensure public health and safety,” the statement concluded.
The Authority also called on the public to report anyone found selling Omama Herbal Mixture to the nearest FDA office.
NKONKONSA.com
